MedPath

Prognosis of Bronchiectasis in Children--A Multicenter Prospective Cohort Study

Conditions
Bronchiectasis
Registration Number
NCT02564731
Lead Sponsor
Baoping XU
Brief Summary

This prospective cohort study is designed to observe of the effect of intervention therapy on the long-term prognosis of children with bronchiectasis. The main purpose of the study was to evaluate the degree of deterioration of lung function, to observe and compare the quality of life, the time of pulmonary exacerbation, and the changes of lung image.

Detailed Description

All enrolled patients are followed up for half a year, 1 years, 2 years, 3 years, 4 years, 5 years, while observation of pulmonary function, symptoms, signs, quality of life, the times of acute pulmonary exacerbation, and the changes of lung image are performed.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria

A included patient must be coincident at least one point of the four items of high-resolution computed tomography (HRCT) manifestations.

  • Internal bronchial diameter greater than the accompanying pulmonary artery.
  • lack of bronchial tapering
  • bronchi visible in the peripheral 1cm of lung
  • bronchial diameter greater than adjacent segmental bronchi
Exclusion Criteria

Subject will be excluded if she or he has one of the following

  • It is unable or doesn't agree to accept the follow-up process
  • undergoing trial for other medications or instruments.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change from baseline in lung function on the spirometry5 years

forced expiratory volume at one second (FEV1) in Liter

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Beijing Children'S Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath